Literature DB >> 26001976

Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease.

Soichiro Ebisawa1, Tairo Kurita2, Nobuyoshi Tanaka1, Kenya Nasu1, Masashi Kimura1, Tatsuya Ito1, Yoshihisa Kinoshita1, Etsuo Tsuchikane1, Mitsuyasu Terashima1, Takahiko Suzuki1.   

Abstract

Contrast-induced nephropathy (CIN) is an important complication following percutaneous coronary intervention (PCI). The clinical importance of a minimum contrast media volume (CMV) for PCI to prevent CIN has not been well evaluated. The purpose of this study was to evaluate the impact of minimum CMV to prevent CIN after PCI. In this study, 2052 consecutive patients who underwent elective PCI in our institute were analyzed. We divided patients into two groups according to CMV: a minimum CMV PCI group [CMV ≤50 ml (n = 94)] and a non-minimum CMV PCI group [CMV >50 ml (n = 1958)]. CIN occurred in 160 (7.8 %) patients. The incidence of CIN was significantly lower in the minimum CMV PCI group than in the non-minimum CMV PCI group (2.1 vs. 8.1 %; P = 0.03). According to multivariate analysis, elderly patients and diabetes mellitus patients were at high risk of developing CIN in this study population. When analyzing only high-risk patients, the incidence of CIN was also significantly lower in the minimum CMV group than in the non-minimum CMV group (2.6 vs. 10.3 %; P = 0.03). Minimum CMV PCI could reduce the incidence of CIN, particularly in high-risk patients; as such, defining the minimum CMV clinical cut-off values may be useful for the prevention of CIN.

Entities:  

Keywords:  Contrast media volume; Contrast-induced nephropathy; Percutaneous coronary intervention

Mesh:

Substances:

Year:  2015        PMID: 26001976     DOI: 10.1007/s12928-015-0337-1

Source DB:  PubMed          Journal:  Cardiovasc Interv Ther        ISSN: 1868-4297


  3 in total

1.  Ultra-minimum contrast percutaneous coronary intervention for a patient with complex coronary artery disease and end-stage diabetic nephropathy.

Authors:  Keita Shibata; Kohei Wakabayashi; Ryota Kosaki; Chisato Sato; Tenjin Nishikura; Toshiro Shinke; Kaoru Tanno
Journal:  J Cardiol Cases       Date:  2021-04-09

2.  Association Between Acidosis Soon After Reperfusion and Contrast-Induced Nephropathy in Patients With a First-Time ST-Segment Elevation Myocardial Infarction.

Authors:  Masaomi Gohbara; Azusa Hayakawa; Yusuke Akazawa; Shuta Furihata; Ai Kondo; Yusuke Fukushima; Sakie Tomari; Tsutomu Endo; Kazuo Kimura; Kouichi Tamura
Journal:  J Am Heart Assoc       Date:  2017-08-23       Impact factor: 5.501

3.  The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.

Authors:  Jingjing Zhao; Huahua Liu; Buyun Xu; Jiahao Peng; Yangbo Xing; Weiliang Tang; Fang Peng
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-27       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.